Screener
BridgeBio Pharma BBIO Net gains (losses) on investments
Net gains (losses) on investments at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by BridgeBio Pharma in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromEquityMethodInvestments.
The source filing: BridgeBio Pharma’s 10-Q, filed August 10, 2026.
- Filed
- Aug 10, 2026, 4:31 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001743881-26-000027
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Interest expense | (13,278) | (11,607) | (26,220) | (29,728) |
| Noncash interest expense on deferred royalty obligations (1) | (41,345) | (26,030) | (81,218) | (50,050) |
| Loss on extinguishment of debt | — | — | — | (21,155) |
| Net loss from equity method investments | (6,435) | (20,189) | (24,718) | (35,745) |
| Other income, net | 5,587 | 6,548 | 9,840 | 14,779 |
| Total other expense, net | (48,812) | (47,380) | (109,411) | (112,616) |
| Loss before income taxes | (155,891) | (181,658) | (322,446) | (351,266) |
| Provision for income taxes | — | 2,100 | — | 2,100 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is BridgeBio Pharma's net gains (losses) on investments?
- BridgeBio Pharma (BBIO) reported net gains (losses) on investments of -$6.44M in Q2 2026.
- How has BridgeBio Pharma's net gains (losses) on investments changed year-over-year?
- BridgeBio Pharma's net gains (losses) on investments increased by 68.1% year-over-year, from -$20.19M to -$6.44M.
- What is the long-term trend for BridgeBio Pharma's net gains (losses) on investments?
- Over 2 years (2021 to 2025), BridgeBio Pharma's net gains (losses) on investments has grown at a -100.0% compound annual growth rate (CAGR), from $29.91M to $0.
- What does net gains (losses) on investments mean?
- Realized and unrealized gains/losses on investments removed from operating cash flow since they're investing-related.
Ask your AI about BridgeBio Pharma's net gains (losses) on investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude